PCSK9 inhibitors are a class of drugs used to lower LDL cholesterol levels by preventing the degradation of LDL receptors in the liver, thus enhancing the liver's ability to remove LDL cholesterol from the blood. They are particularly beneficial for patients who are unable to achieve target cholesterol levels with statins alone or who are statin-intolerant.